StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

175 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-28

Study Completion Date

2021-12-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Healthy.io Method Comparison & User Performance Study

NCT02785445

Urinary Tract Infection Kidney Failure Diabetes

COMPLETED NA

Evaluation of the Analytical Performance of ALLEGRO™ Instrument

NCT04096313

Diabetes Mellitus Kidney Diseases Metabolic Disease

COMPLETED

Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples

NCT02897154

Analytical Performance of Sodium, Glucose and Hematocrit Assays by the i-STAT 500 (Alinity) Analyzer

COMPLETED

A Comparative, Controlled Study to Evaluate the Lay User Accuracy and Performance of the Dip Home-Based Dipstick Analyzer

NCT04466774

Urine Detectable Acute and Chronic Diseases

COMPLETED NA

StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood

NCT05118048

Sepsis Anemia Bleeding +1 more

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To assess the performance of the StatStrip A Glucose/Creatinine assay in the hands of lay users on capillary whole blood obtained by finger stick and compare with the performance characteristics to a central laboratory traceable reference method.

To assess the Ease of Use of the StatStrip Glucose / Creatinine Meter System in the hands of the intended lay users. Lay users will be provided with all package insert sheets, a Quick Reference Guide and Instructions for Use (IFU) Manual. No training, coaching, or prompting will be provided to the lay users other than clarifying the protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabete Mellitus CKD ESRD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glucose, Creatinine

Compare diagnostic tests to reference methods

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult subjects (≥ 18 years old) with diabetes.
* Adult subjects (≥ 18 years old) with kidney diseases (CKD, ESRD) and/or in dialysis.
* Adult subjects (≥ 18 years old) that are healthy.
* Subjects willing to complete all study procedures.
* Subjects whose pre-screen glucose or creatinine medical history is deemed of value by the study site
* Subjects able to read, write, speak in English.

Exclusion Criteria

* Subjects unable to consent to participating in the study.
* Subjects possessing a cognitive disorder or other condition, which, in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study.
* Subjects taking prescription anticoagulants (such as Warfarin or Heparin) or has clotting problems that may prolong bleeding.
* Subjects having hemophilia or any other bleeding disorder.
* Subjects having an infection with a blood borne pathogen (e.g. HIV, hepatitis).
* Subjects working for a medical device or diagnostic company.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes